Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes

JAMA. 2023 Aug 8;330(6):561-563. doi: 10.1001/jama.2023.12945.
No abstract available

Plain language summary

This study examines the use of COVID-19 antiviral treatments in US nursing homes and the facility characteristics associated with use of oral antivirals and monoclonal antibodies.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Antiviral Agents* / administration & dosage
  • Antiviral Agents* / therapeutic use
  • COVID-19 Drug Treatment* / methods
  • COVID-19* / therapy
  • Humans
  • Nursing Homes*
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal
  • Antiviral Agents